Xia, Weibo
Cooper, Cyrus
Li, Mei
Xu, Ling
Rizzoli, Rene
Zhu, Mei
Lin, Hua
Beard, John
Ding, Yue
Yu, Wei
Cavalier, Etienne
Zhang, Zhenlin
Kanis, John A.
Cheng, Qun
Wang, Quimei
Reginster, Jean-Yves http://orcid.org/0000-0001-6290-752X
Article History
Received: 18 June 2019
Accepted: 18 July 2019
First Online: 2 August 2019
Compliance with ethical standards
:
: C. Cooper reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB, outside of the submitted work. J-Y. Reginster reports grants from IBSA-Genevrier, Mylan, CNIEL, Radius Health (through institution), consulting fees from IBSA-Genevrier, Mylan, CNIEL, Radius Health, Pierre Fabre, fees for participation in review activities from IBSA-Genevrier, MYLAN, CNIEL, Radius Health, Teva, payment for lectures from AgNovos, CERIN, CNIEL, Dairy Research Council (DRC), Echolight, IBSA-Genevrier, Mylan, Pfizer Consumer Health, Teva, Theramex, outside of the submitted work. R. Rizzoli reports personal fees for lecture or advisory boards from Radius Health, Labatec, Efryx, Nestlé, ObsEva, Sandoz, Cniel, Mylan, Echolight and Danone, outside of the submitted work. J. A. Kanis reports grants from UCB, grants from Amgen, grants from Radius Health, outside the submitted work; and Dr Kanis is a member of the National Osteoporosis Guideline Group (NOGG) and the principal architect of FRAX but derives no financial benefit. All other authors report nothing to disclose relating to the submitted work: Weibo Xia, Mei Li Ling Xu, Mei Zhu, Hua Lin, John Beard, Yue Ding, Wei Yu, Etienne Cavalier, Zhenlin Zhang, Qun Cheng, Quimei Wang.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study formal consent is not required.